Ensol Biosciences Inc.
Develops AI-discovered peptide drugs for cancer, osteoarthritis, and Alzheimer's disease.
140610 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 대전광역시 유성구 테크노10로 51(탑립동), 대전광역시
- Website:
- https://www.ensolbio.co.kr/eng/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Ensol Biosciences Inc. is a clinical-stage biopharmaceutical company developing innovative drugs for diseases with high unmet medical needs. The company specializes in creating PPI (Protein-Protein Interaction)-regulating short peptide drugs, utilizing a proprietary bio big data and AI platform for discovery and development. Its therapeutic approach focuses on local, non-blood injections to maximize efficacy, ensure high target specificity, and minimize systemic side effects due to a short half-life in the bloodstream. Ensol's clinical pipeline targets conditions such as osteoarthritis, degenerative disc disease, cancer, and Alzheimer's disease. Key candidates include E1K for osteoarthritis (preparing for Phase 3) and C1K, a combination cancer therapy (Phase 1).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-08 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 66.6 KB | ||
| 2025-08-08 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.4 KB | ||
| 2025-08-06 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 67.6 KB | ||
| 2025-08-06 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 26.8 KB | ||
| 2025-07-31 00:00 |
Share Issue/Capital Change
증권발행결과(자율공시)
|
Korean | 5.1 KB | ||
| 2025-07-22 00:00 |
Share Issue/Capital Change
주요사항보고서(유상증자결정)
|
Korean | 38.5 KB | ||
| 2025-07-21 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 66.3 KB | ||
| 2025-07-21 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.4 KB | ||
| 2025-07-18 00:00 |
Share Issue/Capital Change
증권발행결과(자율공시)
|
Korean | 5.1 KB | ||
| 2025-07-10 00:00 |
Share Issue/Capital Change
주요사항보고서(유상증자결정)
|
Korean | 31.0 KB | ||
| 2025-06-12 00:00 |
Major Shareholding Notification
최대주주변경
|
Korean | 22.0 KB | ||
| 2025-06-12 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 84.8 KB | ||
| 2025-06-11 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 67.9 KB | ||
| 2025-06-11 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.8 KB | ||
| 2025-06-11 00:00 |
Major Shareholding Notification
최대주주변경을수반하는주식양수도계약체결
|
Korean | 9.3 KB |
Automate Your Workflow. Get a real-time feed of all Ensol Biosciences Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Ensol Biosciences Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
